Search research articles
Contact Us
Filters
Showing results (1191-1200 of 1,249) with videos related to
Page
of 125
Sort By:
Haematologica
|
June 24, 2021
Natural history of Waldenström macroglobulinemia following acquired resistance to ibrutinib monotherapy
Joshua N Gustine, Shayna Sarosiek, Catherine A Flynn, et al.
British Journal of Haematology
|
July 4, 2019
CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenström macroglobulinaemia treated with ibrutinib
Jorge J Castillo, Lian Xu, Joshua N Gustine, et al.
British Journal of Haematology
|
February 18, 2009
Expression of regulatory genes for lymphoplasmacytic cell differentiation in Waldenstrom Macroglobulinemia
Xavier Leleu, Zachary R Hunter, Lian Xu, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
May 28, 2021
Challenges Faced by Rural Primary Care Providers When Caring for COPD Patients in the Western United States
Fernando Diaz Del Valle, Patricia B Koff, Sung-Joon Min, et al.
European Journal of Haematology
|
March 12, 2008
Clinical relevance of soluble HLA class I molecules in Waldenstrom Macroglobulinemia
Anne-Sophie Moreau, Yasmine Sebti, Alain Duhamel, et al.
Experimental Gerontology
|
February 27, 2018
Human neuromuscular aging: Sex differences revealed at the myocellular level
Brandon M Roberts, Kaleen M Lavin, Gina M Many, et al.
Multiple Sclerosis and Related Disorders
|
October 15, 2021
COVID-19 in Multiple Sclerosis: Clinically reported outcomes from the UK Multiple Sclerosis Register
R M Middleton, E M Craig, W J Rodgers, et al.
Blood Advances
|
November 8, 2018
Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia
Zachary R Hunter, Lian Xu, Nickolas Tsakmaklis, et al.
The New England Journal of Medicine
|
August 31, 2012
MYD88 L265P somatic mutation in Waldenström's macroglobulinemia
Steven P Treon, Lian Xu, Guang Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2009
Lenalidomide and rituximab in Waldenstrom's macroglobulinemia
Steven P Treon, Jacob D Soumerai, Andrew R Branagan, et al.
Page
of 125
Search research articles
Search
Showing results (1191-1200 of 1,249) with videos related to
Sort By:
Page
of 125
Haematologica
|
June 24, 2021
Natural history of Waldenström macroglobulinemia following acquired resistance to ibrutinib monotherapy
Joshua N Gustine, Shayna Sarosiek, Catherine A Flynn, et al.
British Journal of Haematology
|
July 4, 2019
CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenström macroglobulinaemia treated with ibrutinib
Jorge J Castillo, Lian Xu, Joshua N Gustine, et al.
British Journal of Haematology
|
February 18, 2009
Expression of regulatory genes for lymphoplasmacytic cell differentiation in Waldenstrom Macroglobulinemia
Xavier Leleu, Zachary R Hunter, Lian Xu, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
May 28, 2021
Challenges Faced by Rural Primary Care Providers When Caring for COPD Patients in the Western United States
Fernando Diaz Del Valle, Patricia B Koff, Sung-Joon Min, et al.
European Journal of Haematology
|
March 12, 2008
Clinical relevance of soluble HLA class I molecules in Waldenstrom Macroglobulinemia
Anne-Sophie Moreau, Yasmine Sebti, Alain Duhamel, et al.
Experimental Gerontology
|
February 27, 2018
Human neuromuscular aging: Sex differences revealed at the myocellular level
Brandon M Roberts, Kaleen M Lavin, Gina M Many, et al.
Multiple Sclerosis and Related Disorders
|
October 15, 2021
COVID-19 in Multiple Sclerosis: Clinically reported outcomes from the UK Multiple Sclerosis Register
R M Middleton, E M Craig, W J Rodgers, et al.
Blood Advances
|
November 8, 2018
Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia
Zachary R Hunter, Lian Xu, Nickolas Tsakmaklis, et al.
The New England Journal of Medicine
|
August 31, 2012
MYD88 L265P somatic mutation in Waldenström's macroglobulinemia
Steven P Treon, Lian Xu, Guang Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2009
Lenalidomide and rituximab in Waldenstrom's macroglobulinemia
Steven P Treon, Jacob D Soumerai, Andrew R Branagan, et al.
Page
of 125